OTCMKTS:CSRMY - CONSORT Med PLC/S Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$10.80
Today's Range$10.80 - $10.80
52-Week Range$13.25 - $16.65
Volume92 shs
Average Volume190 shs
Market Capitalization$532.22 million
P/E Ratio12.56
Dividend Yield1.57%
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is based in Hemel Hempstead, the United Kingdom.

Receive CSRMY News and Ratings via Email

Sign-up to receive the latest news and ratings for CSRMY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Private households
Previous SymbolNASDAQ:CSRMY



Sales & Book Value

Annual Sales$416.41 million
Book Value$6.69 per share



Market Cap$532.22 million
Next Earnings DateN/A
OptionableNot Optionable

CONSORT Med PLC/S (OTCMKTS:CSRMY) Frequently Asked Questions

What is CONSORT Med PLC/S's stock symbol?

CONSORT Med PLC/S trades on the OTCMKTS under the ticker symbol "CSRMY."

How often does CONSORT Med PLC/S pay dividends? What is the dividend yield for CONSORT Med PLC/S?

CONSORT Med PLC/S declared a Semi-Annual dividend on Tuesday, December 18th. Investors of record on Friday, January 18th will be given a dividend of $0.085 per share on Monday, February 25th. The ex-dividend date is Thursday, January 17th. View CONSORT Med PLC/S's Dividend History.

Has CONSORT Med PLC/S been receiving favorable news coverage?

Media headlines about CSRMY stock have trended very positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. CONSORT Med PLC/S earned a news impact score of 3.6 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days.

Who are some of CONSORT Med PLC/S's key competitors?

What other stocks do shareholders of CONSORT Med PLC/S own?

Who are CONSORT Med PLC/S's key executives?

CONSORT Med PLC/S's management team includes the folowing people:
  • Mr. Jonathan M. Glenn, CEO & Director (Age 49)
  • Mr. Paul Hayes, CFO & Exec. Director (Age 51)
  • Mr. Andrew Jackson, Group Gen. Counsel & Company Sec.
  • Ms. Lisa King, Director of HR
  • Colin Leeder, Group Financial Controller

How do I buy shares of CONSORT Med PLC/S?

Shares of CSRMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How big of a company is CONSORT Med PLC/S?

CONSORT Med PLC/S has a market capitalization of $0.00 and generates $416.41 million in revenue each year. The company earns $21.54 million in net income (profit) each year or $0.86 on an earnings per share basis.

What is CONSORT Med PLC/S's official website?

The official website for CONSORT Med PLC/S is http://www.consortmedical.com.

How can I contact CONSORT Med PLC/S?

CONSORT Med PLC/S's mailing address is Breakspear Park Suite B Breakspear Way, Hemel Hempstead X0, HP2 4TZ. The company can be reached via phone at 44-14-4286-7920.

MarketBeat Community Rating for CONSORT Med PLC/S (OTCMKTS CSRMY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  85 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  176
MarketBeat's community ratings are surveys of what our community members think about CONSORT Med PLC/S and other stocks. Vote "Outperform" if you believe CSRMY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CSRMY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/19/2019 by MarketBeat.com Staff

Featured Article: How Do Mutual Funds Work?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel